Patents Examined by Yong Pak
  • Patent number: 9957489
    Abstract: The present invention pertains to a process for production of recombinant arylsulfatase A in a cell culture system, the process comprising culturing a mammalian cell capable of producing rASA in liquid medium in a system comprising one or more bio-reactors; and concentrating, purifying and formulating the rASA by a purification process comprising one or more steps of chromatography. Other aspects of the invention provides a pharmaceutical composition comprising rASA, which is efficiently endocytosed via the mannose-6-phosphate receptor pathway in vivo as well as a rhASA a medicament and use of a rhASA for the manufacture of a medicament for reducing the galactosyl sulphatide levels within target cells in the peripheral nervous system and/or within the central nervous system in a subject.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: May 1, 2018
    Assignee: Shire Pharmaceuticals Ireland Limited
    Inventors: Jens Fogh, Claes Andersson, Cecilia Weigelt, Christer Moller, Pia Hyden
  • Patent number: 9944913
    Abstract: The present invention relates to variants of a parent glucoamylase having altered properties (e.g., improved thermostability and/or specific activity). In particular, the present invention provides compositions comprising the variant glucoamylases, including starch hydrolyzing compositions, animal feed compositions and cleaning compositions. The invention also relates to DNA constructs encoding the variants and methods of producing the glucoamylase variants in host cells.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: April 17, 2018
    Assignee: Danisco US Inc.
    Inventors: Wolfgang Aehle, Piet Van Solingen, Martijn Scheffers, Richard Bott
  • Patent number: 9896679
    Abstract: The present invention provides a fused NHase with improved specific activity and stability, which relates to the field of genetic engineering. This invention provides a method of overexpressing a fused NHase in E. coli and producing a mutant NHase with improved stability and product tolerance. The invention provides a simple, efficient and safe method of making mutant NHase, and can produce a large amount of soluble NHases in a short period. The present invention makes a contribution to large-scale industrial production and further theoretical study of NHases.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: February 20, 2018
    Assignee: Jiangnan University
    Inventors: Zhemin Zhou, Wenjing Cui, Zhongmei Liu, Li Zhou, Yuanyuan Xia
  • Patent number: 9890197
    Abstract: The present invention provides for peptides that bind to Receptor for Hyaluronic Acid Mediated Motility (RHAMM) molecules. More specifically, provided are peptides capable of specifically binding RHAMM molecules and capable of binding RHAMM with substantially high affinity. These novel RHAMM-binding peptides provide the basis for new imaging probes that can be used to identify cells expressing RHAMM, and for methods of imaging, prognosis, diagnosis and treatment of conditions associated with RHAMM expression.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: February 13, 2018
    Assignee: London Health Sciences Centre Research Inc.
    Inventors: Leonard G. Luyt, Eva A. Turley, Kenneth Virgel Esguerra
  • Patent number: 9879294
    Abstract: Provided are methods for degrading or converting a cellulosic material, comprising: treating the cellulosic material with an enzyme composition in the presence of a polypeptide having catalase activity; and enzyme composition used for degrading or converting a cellulosic material comprising one or more (e.g., several) enzymes having cellulolytic and/or hemicellulolytic activity and a polypeptide having catalase activity.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: January 30, 2018
    Assignee: Novozymes A/S
    Inventors: Hongzhi Huang, Haiyu Ren
  • Patent number: 9873898
    Abstract: The present invention provides a method for producing an L-amino acid by fermentation using a bacterium of the family Enterobacteriaceae. The bacterium can belong to the genus Escherichia, which has been modified to attenuate expression of a phosphate transporter-encoding gene, such as the pitA gene or pitB gene.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: January 23, 2018
    Assignee: AJINOMOTO CO., INC.
    Inventors: Tatyana Mikhailovna Kuvaeva, Evgeniya Aleksandrovna Polyakova, Natalia Viktorovna Stoynova
  • Patent number: 9850470
    Abstract: Disclosed is a novel polyene-specific glycosyltransferase derived from Pseudonocardia autotrophica. The glycosyltransferase includes an amino acid sequence of SEQ ID NO: 1 and a gene encoding the glycosyltransferase. The glycosyltransferase is produced by a method which includes the steps of: culturing transgenic recombinant microorganisms; and isolating glycosyltransferase from the cultured recombinant microorganisms.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: December 26, 2017
    Assignee: INHA-INDUSTRY PARTNERSHIP INSTITUTE
    Inventors: Eung Soo Kim, Mi Jin Lee, Hye Jin Kim
  • Patent number: 9828594
    Abstract: The invention relates to nitrilases and to nucleic acids encoding the nitrilases. In addition methods of designing new nitrilases and method of use thereof are also provided. The nitrilases have increased activity and stability at increased pH and temperature.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: November 28, 2017
    Assignee: BASF Enzymes LLC
    Inventors: Kelvin Wong, Jay M. Short, Mark J. Burk, Grace Desantis, Robert Farwell, Kelly Chatman
  • Patent number: 9822384
    Abstract: Exemplary embodiments provided herein include genetically engineering microorganisms, such as yeast or bacteria, to produce cannabinoids by inserting genes that produce the appropriate enzymes for the metabolic production of a desired compound.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: November 21, 2017
    Assignee: Librede Inc.
    Inventors: Jason L. Poulos, Anthony N. Farnia
  • Patent number: 9822387
    Abstract: An acetyl-CoA-producing microorganism, which is capable of efficiently synthesizing acetyl-CoA using carbon dioxide, and a substance production method using the same are provided. An acetyl-CoA-producing microorganism including an acetyl-CoA production cycle obtained by imparting at least one type of enzymatic activity selected from the group consisting of malate thiokinase, malyl-CoA lyase, glyoxylate carboligase, 2-hydroxy-3-oxopropionate reductase, and hydroxypyruvate reductase, to a microorganism.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: November 21, 2017
    Assignee: MITSUI CHEMICALS, INC.
    Inventors: Ryota Fujii, Tomokazu Shirai, Tadashi Araki, Koh Amano, Yoshiko Matsumoto, Toshihiro Tateno, Nozomi Takebayashi, Takashi Morishige, Hitoshi Takahashi, Mitsufumi Wada, Hiroshi Shimizu, Chikara Furusawa, Takashi Hirasawa, Tomonori Hidesaki, Ayako Endo, Dominik Lukas Jürgen-Lohmann, Anjali Madhavan, Su Sun Chong
  • Patent number: 9816114
    Abstract: Systems and methods for the production of malonate in recombinant host cells.
    Type: Grant
    Filed: March 6, 2013
    Date of Patent: November 14, 2017
    Assignee: Lygos, Inc.
    Inventors: Jeffrey A. Dietrich, Jeffrey L. Fortman, Eric J. Steen
  • Patent number: 9783809
    Abstract: The present invention concerns a eukaryotic host selected from microorganisms, and a method for producing glycolic acid using said eukaryotic host cells, especially cells of a genetically modified fungal host. Further this invention relates to a glycolic acid product obtained using the method described here and the use of genetically modified microorganism cells in production of glycolic acid.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: October 10, 2017
    Assignee: Teknologian tutkimuskeskus VTT Oy
    Inventors: Outi Koivistoinen, Joosu Kuivanen, Peter Richard, Merja Penttilä
  • Patent number: 9765307
    Abstract: The present invention pertains to an isolated P450 enzyme comprising or consisting of an amino acid sequence at least 80% identical to SEQ ID NO: 1, wherein said sequence comprises a threonine at position corresponding to position 225 and/or an aspartic acid mutation at position corresponding to position 289. The invention also concerns an isolated nucleic acid comprising a sequence encoding said enzyme, a vector comprising said nucleic acid, and a host cell containing said nucleic acid or said vector. Methods for preparing said enzyme and methods for producing steroid hormone precursors using the enzyme or the host cells featured in the invention are also provided.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: September 19, 2017
    Assignee: SANOFI
    Inventors: Marine Bertin, Bruno Dumas
  • Patent number: 9745602
    Abstract: The present invention relates to the control of gene expression by a heterologous glucose-regulated promoter, to microorganisms in which gene expression is controlled by a heterologous glucose-regulated promoter and to methods using said microorganisms for the production of terpenes during glucose-limited fed-batch fermentation.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: August 29, 2017
    Assignee: FIRMENICH SA
    Inventors: Laurent Daviet, Michel Schalk, Jens Nielsen, Verena Siewers, Christoph Knuf, Gionata Scalcinati
  • Patent number: 9745608
    Abstract: Recombinant microorganisms comprising DNA molecules in a deregulated form which improve the production of cadaverine or N-acetylcadaverine, as well as recombinant DNA molecules and polypeptides used to produce the microorganisms are provided. Said microorganisms comprise an intracellular lysine decarboxylase activity and a deregulated cadaverine export activity, or comprise a decreased cadaverine export activity and an enhanced N-acetylcadaverine forming activity. Processes for the production of cadaverine N-acetylcadaverine using the recombinant microorganisms are also provided.
    Type: Grant
    Filed: February 20, 2012
    Date of Patent: August 29, 2017
    Assignee: BASF SE
    Inventors: Christoph Wittmann, Stefanie Kind
  • Patent number: 9725748
    Abstract: [Problem] To provide a production method capable of simply and efficiently producing a fructose-added carbohydrate using ?-fructofuranosidase. [Solution] A method for producing a fructose-added carbohydrate, said method having a step in which a receptor substrate and a hydrate containing terminal fructose residue are brought into contact with: Escherichia coli expressing an anchor protein for expression on a cell surface and ?-fructofuranosidase as one polypeptide, a composition including dead cells of the expressing Escherichia coli, or a polypeptide obtained from the expressing Escherichia coli and including an amino acid sequence of ?-fructofuranosidase.
    Type: Grant
    Filed: December 26, 2014
    Date of Patent: August 8, 2017
    Assignees: Microbiopharm Japan Co., Ltd., B Food Science Co., Ltd.
    Inventors: Takumi Tochio, Naomi Ito, Saki Nakamura, Tadashi Fujii, Keisuke Tamura
  • Patent number: 9719079
    Abstract: This invention relates to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In some embodiments, the invention is directed to polypeptides having aldolase activity, including pyruvate activity such as, without limitation, HMG and/or KHG aldolase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides in accordance with the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: August 1, 2017
    Assignee: BASF Enzymes LLC
    Inventors: David P. Weiner, Lishan Zhao, Peter Luginbuhl, Ellen Burke, Toby H. Richardson, Paula M. Hicks
  • Patent number: 9717252
    Abstract: Derivatives of Agrobacterium vitis strain F2/5 are disclosed. These derivatives were generated following homologous recombination with an internal fragment of targeted genes resulting in gene disruption by insertion of a copy of suicide vector pVIK165. The genes disrupted were F-avi5813 encoding a phosphopantetheinyltransferase, F-avi4329 encoding an aminotransferase and F-avi0838 (rirA) encoding an iron responsive transcriptional regulator. Such derivatives control crown gall on grapevines. In addition, these derivatives did not induce roots necrosis but enhanced root development and callus formation. On young stem explants, it was shown as well that the F2/5 derivatives are necrosis-negative.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 1, 2017
    Assignee: Cornell University
    Inventors: Thomas J. Burr, Desen Zheng
  • Patent number: 9701991
    Abstract: Disclosed herein are enzymes useful for the degradation of cellobiosan in materials such a pyrolysis oils. Methods of degrading cellobiosan using enzymes or organisms expressing the same are also disclosed.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: July 11, 2017
    Assignee: Alliance for Sustainable Energy, LLC
    Inventors: Jeffrey Linger, Gregg T. Beckham
  • Patent number: 9677053
    Abstract: Provided herein are isolated laccase enzymes and nucleic acids encoding them. Also provided are mediators for laccase reactions. Also provided herein are methods for using laccases to oxidize lignins, other phenolic, and aromatic compounds, such as for bio-bleaching and decolorization of wood pulp under high temperature and pH conditions to facilitate a substantial reduction in use of bleaching chemicals, as well as for treatment of fibers.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: June 13, 2017
    Assignees: BASF Enzymes LLC, BASF SE
    Inventors: Janne Samuli Kerovuo, Sylke Haremza, Oliver Koch, Tilo Habicher, Dan E. Robertson, Grace Desantis, Ryan McCann, Peter Luginbuhl